TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Laurantis Pharma Oy
Closing information (x1000 SEK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
18
|
10 | |
Financial expenses |
364
|
36,668
|
933 |
Earnings before taxes |
-5,922
|
-59,040
|
-15,891 |
Total assets |
2,727
|
767
|
55,437 |
Current assets |
2,564
|
612
|
714 |
Current liabilities |
1,636
|
1,754
|
1,542 |
Equity capital |
-35,445
|
-28,200
|
32,124 |
- share capital |
29
|
27
|
29 |
Employees (average) | 1 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
-1299.8%
|
-3676.7%
|
57.9% |
Turnover per employee | |||
Profit as a percentage of turnover |
-328000%
|
-158910.0% | |
Return on assets (ROA) |
-203.8%
|
-2916.8%
|
-27.0% |
Current ratio |
156.7%
|
34.9%
|
46.3% |
Return on equity (ROE) |
16.7%
|
209.4%
|
-49.5% |
Change turnover |
9
|
10 | |
Change turnover % | 100% | ||
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.